Skip to main content

Table 1 Logistic regression analysis with adherence (> 4 h /day, 70% of the days) as the dependent variable

From: Is the 2013 American Thoracic Society CPAP-tracking system algorithm useful for managing non-adherence in long-term CPAP-treated patients?

 

Whole population

Non adherent

N = 100

Adherent

N = 550

Crude OR [95% CI]

p-value

Adjusted OR [95% CI]

p-value

Demographics

 Age (yrs)

68 [61; 74]

68 [60; 75]

68 [61; 74]

1.00 [0.98; 1.02]

0.80

  

 Gender, female (%)

173/650 (26.6)

32/100 (32.0)

141/550 (25.6)

0.73 [0.46; 1.16]

0.19

  

 BMI (kg/m2)

30.8 [27.7; 34.5]

29.4 [26.5; 32.3]

31.1 [27.8; 34.9]

1.07 [1.02; 1.12]

0.003

1.07 [1.01; 1.13]

0.03

 Initial AHI (event/h)

39 [31; 55]

37.9 [30.0; 52.0]

39.0 [31.0; 57.0]

1.01 [0.99; 1.02]

0.16

  

 Active smokers (%)

77/637 (12.1]

13/99 (13.1)

64/538 (11.9)

0.89 [0.47; 1.69]

0.73

  

 Beard (%)

75/456 (16.5)

10/64 (15.6)

65/392 (16.6)

1.05 [0.50; 2.18]

0.70

  

 Mustache (%)

42/456 (9.2)

7/64 (10.9)

35/392 (8.9)

0.81 [0.34; 1.92]

0.60

  

 No mustache no beard (%)

339/456 (74.3)

47/64 (73.4)

292/392 (74.5)

Ref

0.88

  

 Presence of partner

457/640 (71.4)

61/96 (63.5)

396/544 (72.8)

1.54 [0.97; 2.42]

0.07

2.03 [1.18; 3.50]

0.011

 Active workers

130/632 (20.6)

20/95 (21.1)

110/537 (20.5)

0.97 [0.57; 1.65]

0.90

  

 ESS (VAS score)

5 [3; 8]

6 [3; 8]

5 [3; 9]

0.99 [0.95; 1.05]

0.87

  

EQ-5D-3 L

 Problems with mobility (%)

157/623 (25.2)

25/94 (26.6)

132/529 (26.6)

0.92 [0.58; 1.51]

0.74

  

 Problems with self-care (%)

38/617 (6.2)

6/94 (6.38)

32/523 (6.12)

0.96 [0.39; 2.35]

0.92

  

 Problems with usual activities (%)

124/620 (20.0)

20/96 (20.8)

104/524 (19.9)

0.94 [0.55; 1.61]

0.82

  

 Problems of pain/discomfort (%)

347/623 (55.7)

54/96 (56.3)

293/527 (55.6)

0.97 [0.63; 1.51]

0.91

  

 Problems of anxiety/depression (%)

240/624 (38.5)

41/96 (42.7)

199/528 (37.9)

0.81 [0.52; 1.26]

0.35

  

 EQ-5D-3 L Health (VAS score)

69.8 [50.2; 80.1]

69.2 [49.4; 80.0]

69.9 [50.4; 80.2]

1.01 [0.99; 1.02]

0.17

  

Device

 Treatment duration (yrs)

4.9 [2.1; 9.8]

3.8 [1.3; 8.1]

5.1 [2.3; 10.2]

1.06 [1.01; 1.11]

0.02

  

 Fixed pressure (%)

91/650 (14.0)

12/100 (12.0)

79/550 (14.4)

1.23 [0.64; 2.35]

0.53

  

 90th/95th Pressure (cmH2O)

10.0 [8.30; 11.8]

9.9 [8.0; 11.5]

10.0 [8.3; 11.8]

1.10 [0.99; 1.21]

0.09

  

 Oronasal (%)

216/650 (33.2)

43/100 (43.0)

173/550 (31.5)

0.58 [0.37; 0.91]

0.14

  

 Nasal (%)

375/650 (57.7)

47/100 (47.0)

328/550 (59.6)

Ref

0.07

  

 Nasal pillows (%)

59/650 (9.1)

10/100 (10.0)

49/550 (8.91)

0.70 [0.33; 1.48]

0.83

  

 Heated humidifier

386/650 (59.4)

66/100 (66.0)

320/550 (58.2)

0.72 [0.46; 1.12]

0.14

  

 Heated breathing tube

22/650 (3.4)

3/100 (3.0)

19/550 (3.5)

1.16 [0.34; 3.99]

0.82

  

2013 ATS statement tested thresholds

 Current AHIflow (> 10)

23/650 (3.4)

5/100 (5.0)

17/550 (3.1)

0.61 [0.22; 1.68]

0.34

  

 ResMed Nasal large leaks (95th > 24 L)

53/154 (34.4)

10/22 (45.5)

43/132 (32.6)

0.58 [0.23; 1.45]

0.24

  

 ResMed Facial large leaks (95th > 36 L)

28/131 (21.4)

8/23 (34.8)

20/108 (18.5)

0.43 [0.16; 1.14]

0.09

  

 Philips leaks (> 1 h of large leaks)

11/356 (3.1)

1/55 (1.82)

10/301 (3.32)

1.86 [0.23; 14.8]

0.56

  

 Fisher Paykel leaks (>  60 L/min)

8/8 (100)

0/8 (0)

8/8 (100)

NA

   

VAS scores

 Patient perceived leaks (VAS score)

3 [1; 5]

3.0 [1.0; 6.0]

3.0 [0.0; 5.0]

0.97 [0.91; 1.05]

0.48

  

 Patient perceived mouth dryness (VAS score)

3 [0; 7]

5 [1; 8]

3 [0; 7]

0.93 [0.88; 0.99]

0.019